Bessemer Group Inc. lifted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 383.5% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 20,492 shares of the company’s stock after purchasing an additional 16,254 shares during the period. Bessemer Group Inc.’s holdings in Cardinal Health were worth $1,371,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of CAH. Fox Run Management L.L.C. bought a new position in shares of Cardinal Health in the 2nd quarter worth approximately $234,000. State of Alaska Department of Revenue lifted its stake in shares of Cardinal Health by 7.6% in the 2nd quarter. State of Alaska Department of Revenue now owns 8,773 shares of the company’s stock worth $682,000 after purchasing an additional 618 shares during the period. Eqis Capital Management Inc. lifted its stake in shares of Cardinal Health by 6.4% in the 2nd quarter. Eqis Capital Management Inc. now owns 11,161 shares of the company’s stock worth $870,000 after purchasing an additional 675 shares during the period. OLD National Bancorp IN lifted its stake in shares of Cardinal Health by 25.5% in the 2nd quarter. OLD National Bancorp IN now owns 7,250 shares of the company’s stock worth $565,000 after purchasing an additional 1,472 shares during the period. Finally, Oregon Public Employees Retirement Fund raised its stake in Cardinal Health by 1.2% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 89,106 shares of the company’s stock worth $6,943,000 after acquiring an additional 1,100 shares during the period. Hedge funds and other institutional investors own 88.64% of the company’s stock.
Shares of Cardinal Health, Inc. (CAH) opened at $57.07 on Wednesday. The company has a current ratio of 1.06, a quick ratio of 0.52 and a debt-to-equity ratio of 1.35. Cardinal Health, Inc. has a fifty-two week low of $56.69 and a fifty-two week high of $84.88. The stock has a market cap of $18,350.83, a P/E ratio of 11.07, a price-to-earnings-growth ratio of 1.69 and a beta of 0.88.
The firm also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Tuesday, January 2nd will be issued a $0.4624 dividend. This represents a $1.85 dividend on an annualized basis and a dividend yield of 3.24%. The ex-dividend date is Friday, December 29th. Cardinal Health’s dividend payout ratio (DPR) is presently 53.78%.
A number of equities research analysts have commented on CAH shares. BidaskClub cut shares of Cardinal Health from a “sell” rating to a “strong sell” rating in a research note on Wednesday, August 16th. Needham & Company LLC restated a “hold” rating on shares of Cardinal Health in a research note on Sunday, September 10th. Mizuho set a $70.00 target price on shares of Cardinal Health and gave the stock a “hold” rating in a research note on Tuesday, October 24th. Jefferies Group LLC set a $77.00 target price on shares of Cardinal Health and gave the stock a “hold” rating in a research note on Tuesday, August 29th. Finally, Royal Bank Of Canada started coverage on shares of Cardinal Health in a research note on Tuesday, September 19th. They set a “sector perform” rating and a $72.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, twelve have issued a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $74.81.
ILLEGAL ACTIVITY NOTICE: This piece was first reported by Markets Daily and is the property of of Markets Daily. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at https://www.themarketsdaily.com/2017/11/15/bessemer-group-inc-acquires-16254-shares-of-cardinal-health-inc-cah.html.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.